Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA
Back to KYTX Full portfolio

Position in KYTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,848,224
+$1,026,535 QoQ
Shares Held
319,666
+51.4% QoQ
Ownership
0.517%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 120 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. KYTX ranks #167 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in KYTX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,848,224 319,666
2026-03-31 $1,821,689 211,088
2025-12-31 $1,179,004 125,426
2025-09-30 $753,468 125,578
2025-06-30 $364,120 118,606
2025-03-31 $319,164 165,370
2024-12-31 $634,977 169,780
2024-09-30 $814,845 166,635
2024-06-30 $938,077 125,077
2024-03-31 $2,108,419 84,880